Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer

Cancer Chemotherapy and Pharmacology

Volumn 67, Issue 6, 2011, Pages 1423-1428

  Takahari, D ^a   Hamaguchi, T ^b   Yoshimura, K ^c   Katai, H ^b   Ito, S ^a   Fuse, N ^d   Kinoshita, T ^d   Yasui, H ^e   Terashima, M ^e   Goto, M ^f   Tanigawa, N ^f   Shirao, K ^g   Sano, T ^h   Sasako, M ⁱ  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^e SHIZUOKA CANCER CENTER   (Japan)

^f OSAKA MEDICAL COLLEGE   (Japan)

^g OITA UNIVERSITY   (Japan)

^h CANCER INSTITUTE HOSPITAL   (Japan)

ⁱ HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Adjuvant chemotherapy; Cisplatin; Gastric cancer; S 1

Indexed keywords

CISPLATIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; TS 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FATIGUE; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; JAPANESE; LEUKOPENIA; LIVER TOXICITY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STOMACH CANCER; STOMATITIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DRUG COMBINATIONS; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXONIC ACID; PATIENT COMPLIANCE; STOMACH NEOPLASMS; TEGAFUR;

EID: 79959616636     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-010-1432-8     Document Type: Article

References (24)

1. http://www.who.int/mediacentre/factsheets/fs297/en/index.html
2. Cirera L, Balil A, Batise-Alentorn E et al (1999) Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. J Clin Oncol 17:3810-3815
3. Nakajima T, Nashimoto A, Kitamura M et al (1999) Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Lancet 354:273-277 (Pubitemid 29348734)
4. Neri B, Cini G, Andreoli F et al (2001) Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up. Br J Cancer 84:878-880 (Pubitemid 32385827)
5. Bajetta E, Buzzoni R, Mariani L et al (2002) Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian trials in medical oncology (ITMO) group. Ann Oncol 13:299-307 (Pubitemid 34704984)
6. Nashimoto A, Nakajima T, Furukawa H et al (2003) Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosanegative gastric cancer: Japan clinical oncology group 9206-1. J Clin Oncol 21:2282-2287 (Pubitemid 46621864)
7. Chipponi J, Huguier M, Pezet D et al (2004) Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Am J Surg 187:440-445 (Pubitemid 38299517)
8. Popiela T, Kulig J, Czupryna A et al (2004) Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer 7:240-245
9. Bouche O, Ychou M, Burtin P et al (2005) Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol 16:1488-1497 (Pubitemid 41226403)
10. Nitti D, Wils J, Santos GD et al (2006) Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI group and the ICCG. Ann Oncol 17:262-269
11. De Vita F, Giuliani F, Orditura M et al (2007) Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). Ann Oncol 18:1354-1358 (Pubitemid 47305009)
12. Nakajima T, Kinoshita T, Nashimoto A et al (2007) Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Br J Surg 94:1468-1476 (Pubitemid 350275624)
13. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group (2010) Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303:1729-1737
14. Shirasaka T, Shimamoto Y, Ohshimo H et al (1996) Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs 7:548-557 (Pubitemid 26276346)
15. Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810-1820 (Pubitemid 350044801)
16. Koizumi W, Narahara H, Hara T et al (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9:215-221
17. Ajani JA, Rodriguez W, Bodoky G et al (2010) Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial. J Clin Oncol 28(9):1547-1553
18. Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma, 2nd english ed. Gastric Cancer 1:10-24
19. Cascinu S, Labianca R, Barone C et al (2007) Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. J Natl Cancer Inst 99:601-607 (Pubitemid 47073541)
20. Ellenberg SS, Sun W (2007) Adjuvant therapy for gastric cancer: how negative results can help patients. J Natl Cancer Inst 99:580-582 (Pubitemid 47073538)
21. Tsuruoka Y, Kamano T, Kitajima M et al (2006) Effect of gastrectomy on the pharmacokinetics of 5-fluorouracil and gimeracil after oral administration of S-1. Anticancer Drugs 17:393-399 (Pubitemid 44309981)
22. Kochi M, Fujii M, Kanamori N et al (2007) Effect of gastrectomy on the pharmacokinetics of S-1, an oral fluoropyrimidine, in resectable gastric cancer patients. Cancer Chemother Pharmacol 60:693-701 (Pubitemid 47247281)
23. Kim WY, Nakata B, Hirakawa K (2007) Alternative pharmacokinetics of S-1 components, 5-fluorouracil, dihydrofluorouracil and alpha-fluoro-beta-alanine after oral administration of S-1 following total gastrectomy. Cancer Sci 98:1604-1608 (Pubitemid 47308458)
24. Kinura Y, Tamura S, Fujitani K et al (2010) Phase II study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy(OGSG0604). In: 2010 Gastrointestinal cancers symposium abstr #100